Synthesis and cytotoxicity of methyl-substituted 8-quinolineselenolates of ruthenium, rhodium, osmium, and iridium

Chemistry of Heterocyclic Compounds

Volumn 45, Issue 2, 2009, Pages 182-187

  Lukevics, E ^a   Zaruma, D ^b   Ashaks, J ^b   Shestakova, I ^a   Domracheva, I ^a   Bridane, V ^a   Yashchenko, E ^a  

^a LATVIAN INSTITUTE OF ORGANIC SYNTHESIS   (Latvia)

^b RIGA TECHNICAL UNIVERSITY   (Latvia)

Author keywords

And ruthenium; Cytotoxicity; Methyl 8 quinolineselenolates of iridium; Osmium; Rhodium; Synthesis; Toxicity

Indexed keywords

EID: 67650670657     PISSN: 00093122     EISSN: 15738353     Source Type: Journal    
DOI: 10.1007/s10593-009-0248-0     Document Type: Article

References (54)

1. V. Brabec, J. Kasparkova, in: M. Gielen and E. R. T. Tiekink (editors), Metallotherapeutic Drugs and Metal-Based Diagnostic Agents, J. Wiley and Sons Ltd., Chichester (2005), p. 489.
2. PC Bruijnincx PJ Sadler 2008 Current Opinion in Chemical Biology 12 197
3. O. Lentzen, C. Mouchenon, and A. Kirsch-De Mesmaeker, in: M. Gielen and E. R. T. Tiekink (editors), Metallotherapeutic Drugs and Metal-Based Diagnostic Agents, J. Wiley and Sons Ltd., Chichester (2005), p. 359.
4. P. J. Dyson and G. Sava, Dalton Trans., 1929 (2006).
5. I Kostova 2006 Curr. Med. Chem. 13 1085
6. H. A. Wee and P. J. Dyson, Eur. J. Inorg. Chem., 4003 (2006).
7. E. Meggers, G. E. Atilla-Gokcumen, H. Bregman, J. Maksimoska, S. P. Mulcahy, N. Pagano, and D. S. Williams, Synlett, 1177 (2007).
8. SS Karki S Thota SY Darj J Balzarini E De Clercq 2007 Bioorg. Med. Chem. 15 6632
9. CA Vock WH Ang C Scolaro AD Phillips L Lagopoulos L Juillerat-Jeanneret G Sava R Scopelliti PJ Dyson 2007 J. Med. Chem. 50 2166
10. M Auzias B Therrien G Süss-Fink P Štěpnička HA Wee PJ Dyson 2008 Inorg. Chem. 47 578
11. I Bratsos A Bergamo G Sava T Gianferrara E Zangrando E Alessio 2008 J. Inorg. Biochem. 102 606
12. I Bratsos S Jedner A Bergamo G Sava T Gianferrara E Zangrando E Alessio 2008 J. Inorg. Biochem. 102 1120
13. SJ Dougan A Habtemariam SE McHale S Parsons PJ Sadler 2008 Proc. Natl. Acad. Sci. USA 105 11628
14. B Dutta C Scolaro R Scopelliti PJ Dyson K Severin 2008 Organometallics 27 1355
15. A Garza-Ortiz PV Maheswari M Siegler AL Spek J Reedijk 2008 Inorg. Chem. 47 6964
16. M Gras B Therrien G Süss-Fink P Štěpnička AK Renfrew PJ Dyson 2008 J. Organomet. Chem. 693 3419
17. M-G Mendoza-Ferri CG Hartinger RE Eichinger N Stolyarova K Severin MA Jakupec AA Nazarov BK Keppler 2008 Organometallics 27 2405
18. C Tan J Liu H Li W Zheng S Shi L Chen L Ji 2008 J. Inorg. Biochem. 102 347
19. C Tan J Liu L Chen S Shi L Ji 2008 J. Inorg. Biochem 102 1644
20. C. A. Vock, A. K. Renfrew, R. Scopelliti, L. Juillerat-Jeanneret, and P. J. Dyson, Eur. J. Inorg. Chem., 1661 (2008).
21. F Schmitt P Govindaswamy G Süss-Fink WH Ang PD Dyson L Juillerat-Jeanneret B Therrien 2008 J. Med. Chem. 51 1811
22. A Dorcier WH Ang S Bolaño L Gonsalvi L Juillerat-Jeanneret G Laurenzy M Peruzzini AD Phillips F Zanobini PJ Dyson 2006 Organometallics 27 4090
23. F. P. Pruchnik in: M. Gielen and E. R. T. Tiekink (editors), Metallotherapeutic Drugs and Metal-Based Diagnostic Agents, J. Wiley and Sons Ltd., Chichester (2005), p. 379.
24. DA Medvetz KD Stakleff T Schreiber PD Custer K Hindi MJ Panzner DD Blanko MJ Tashner CA Tessier WJ Youngs 2007 J. Med. Chem. 50 1703
25. NJ Wheate CR Brodie JG Collins S Kemp JR Aldrich-Wright 2007 Mini-Rev. Med. Chem. 7 627
26. M Harlos I Ott R Gust H Alborzinia S Wölfe A Kromm WS Sheldrick 2008 J. Med. Chem. 51 3924
27. AFA Peacock A Habtemariam SA Moggach A Prescimone S Parsons PJ Sadler 2007 Inorg. Chem. 46 4049
28. AFA Peacock M Melchart RJ Deeth A Habtemariam S Parsons PJ Sadler 2007 Chem. Eur. J. 13 2601
29. AFA Peacock S Parsons PJ Sadler 2007 J. Am. Chem. Soc. 129 3348
30. H Kostrhunova J Florian O Novakova AFA Peacock PJ Sadler V Brabec 2008 J. Med. Chem. 51 3635
31. IN Stepanenko AA Krokhin RO John A Roller VB Arion MA Jakupec BK Keppler 2008 Inorg. Chem. 47 7338
32. E. Lukevics, I. Shestakova, I. Domracheva, A. Nesterova, D. Zaruma, and J. Ashaks, Khim. Geterotsikl. Soedin., 870 (2006). [Chem. Heterocycl. Comp., 42, 761 (2006)].
33. E. Lukevics, I. Shestakova, I. Domracheva, E. Yashchenko, D. Zaruma, and J. Ashaks, Khim. Geterotsikl. Soedin., 755 (2007). [Chem. Heterocycl. Comp., 43, 634 (2007)].
34. E. Lukevics, D. Zaruma, J. Ashaks, I. Shestakova, I. Domracheva, A. Gulbe, and V. Bridane, Khim. Geterotsikl. Soedin., 711 (2008). [Chem. Heterocycl. Comp., 44, 559 (2008)].
35. J. Ashaks, Yu. Bankovskii, D. Zaruma, I. Shestakova, I. Domracheva, A. Nesterova, and E. Lukevics, Khim. Geterotsikl. Soedin., 905 (2004). [Chem. Heterocycl. Comp., 40, 776 (2004)].
36. MA Scharwitz I Ott R Gust A Kromm WS Sheldrick 2008 J. Inorg. Biochem. 102 1623
37. K El-Bayoumy 1985 Cancer Res. 45 3631
38. BS Reddy T Tanaka B Simi 1985 J. Nat. Cancer. Inst. 75 791
39. E Lukevics P Arsenyan K Rubina I Shestakova I Domracheva A Nesterova J Popelis O Pudova 2000 Appl. Organomet. Chem. 16 235
40. E Lukevics P Arsenyan I Shestakova I Domracheva I Kanepe S Belyakov J Popelis O Pudova 2000 Appl. Organomet. Chem. 16 228
41. SW May 2002 Expert Opinion on Investigational Drugs 11 1261
42. M Koketsu H Ishihara 2003 Curr. Org. Chem. 7 175
43. AJ Duffield-Lillico I Shureiqi SM Lippman 2004 J. Nat. Cancer Inst. 96 1645
44. CW Nogueira G Zeni JBT Rocha 2004 Chem. Rev. 104 6255
45. M Soriano-Garcia 2004 Curr. Med. Chem. 11 1657
46. P. D. Whanger, in: A. S. Award and P. G. Bradford (editors), Nutrition and Cancer Prevention, CRC, Taylor and Francis Group. Boca Raton, London, New York (2006), p. 189.
47. L Letavayová V Vlčková J Brozmanová 2006 Toxicology 227 1
48. G-X Li H Hu C Jiang T Schuster J Lu 2007 Int. J. Cancer 120 2034
49. WM El-Sayed T Aboul-Fadl JC Roberts JG Lamb MR Franklin 2007 Toxicology in Vitro 21 157
50. W Mól M Matyja B Filip J Wietrzyk S Boryczka 2008 Bioorg. Med. Chem. 16 8136
51. E. Lukevics, I. Shestakova, I. Domracheva, A. Nesterova, J. Ashaks, and D. Zaruma, Khim. Geterotsikl. Soedin., 59 (2006). [Chem. Heterocycl. Comp., 42, 53 (2006)].
52. Guidance Document on Using in vitro Data to Estimate in vivo Starting Doses for Acute Toxicity, National Institute of Health, US Dept. of Health and Human Services (2001), p. 12.
53. G Veinberg M Vorona I Shestakova I Kanepe O Zharkova R Mezapuke I Turovskis I Kalvinsh E Lukevics 2000 Bioorg. Med. Chem. 8 1033
54. E Lukevics L Ignatovich I Sleiksha V Muravenko I Shestakova S Belyakov J Popelis 2006 Appl. Organometal. Chem. 20 454